Abstract | OBJECTIVES: METHODS: KEY FINDINGS: CONCLUSIONS: DBTG had an inhibitory effect on bleomycin-induced pulmonary fibrosis and its effect may be associated with the ability of DBTG to inhibit the synthesis of extracellular matrix and balance the MMP/TIMP-1 system.
|
Authors | Jian Gao, Li-Jie Feng, Yan Huang, Ping Li, Du-Juan Xu, Jun Li, Qiang Wu |
Journal | The Journal of pharmacy and pharmacology
(J Pharm Pharmacol)
Vol. 64
Issue 6
Pg. 811-20
(Jun 2012)
ISSN: 2042-7158 [Electronic] England |
PMID | 22571259
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2012 The Authors. JPP © 2012 Royal Pharmaceutical Society. |
Chemical References |
- Collagen Type III
- Collagen Type IV
- Drugs, Chinese Herbal
- Glucosides
- Laminin
- RNA, Messenger
- Tissue Inhibitor of Metalloproteinase-1
- danggui buxue decoction
- Bleomycin
- Hyaluronic Acid
- Matrix Metalloproteinase 9
- Matrix Metalloproteinase 1
|
Topics |
- Angelica sinensis
- Animals
- Astragalus Plant
- Bleomycin
- Collagen Type III
(blood)
- Collagen Type IV
(blood)
- Drugs, Chinese Herbal
(pharmacology, therapeutic use)
- Extracellular Matrix
(metabolism)
- Glucosides
(pharmacology, therapeutic use)
- Hyaluronic Acid
(blood)
- Laminin
(blood)
- Lung
(drug effects, metabolism, pathology)
- Male
- Matrix Metalloproteinase 1
(genetics, metabolism)
- Matrix Metalloproteinase 9
(genetics, metabolism)
- Phytotherapy
- Plant Roots
- Pulmonary Alveoli
(drug effects)
- Pulmonary Fibrosis
(drug therapy, genetics, metabolism)
- RNA, Messenger
(metabolism)
- Rats
- Rats, Wistar
- Tissue Inhibitor of Metalloproteinase-1
(genetics, metabolism)
|